Moxycam-CV 625 LB is a combination antibiotic tablet that contains Amoxycillin, Potassium Clavulanate, and Lactic Acid Bacillus. Amoxycillin is a broad-spectrum antibiotic that fights bacteria, while Potassium Clavulanate inhibits beta-lactamase enzymes, preventing bacterial resistance. Lactic Acid Bacillus helps maintain gut flora balance, reducing antibiotic-associated diarrhea. This combination is effective against a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and more. Moxycam-CV 625 LB is designed to offer a comprehensive approach to bacterial eradication while promoting gastrointestinal health during antibiotic treatment.
Moxycam-CV 625 LB
Moxycam-CV 625 LB is a combination antibiotic tablet that contains Amoxycillin, Potassium Clavulanate, and Lactic Acid Bacillus.
Moxycam-CV 625 LB is used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and other bacterial infections susceptible to its components.
Amoxycillin works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of the bacteria.
Potassium Clavulanate inhibits beta-lactamase enzymes produced by certain bacteria, which helps prevent the bacteria from becoming resistant to Amoxycillin.
Lactic Acid Bacillus is included to help maintain the balance of healthy gut flora and reduce the risk of antibiotic-associated diarrhea.
Common side effects may include nausea, vomiting, diarrhea, and skin rash. These side effects are usually mild and temporary.
Reviews
There are no reviews yet.